What is the prevalence of Russell Silver Syndrome?

Russell Silver Syndrome (RSS) is a rare genetic disorder with an estimated prevalence ranging from 1 in 30,000 to 1 in 100,000 live births. While these figures provide a statistical baseline, the true prevalence of Russell Silver Syndrome is likely higher due to clinical underdiagnosis and the complexity of its genetic markers.

Is Russell Silver Syndrome considered a rare disease?

Yes, Russell Silver Syndrome is classified as a rare disease. Because its primary clinical features—such as severe intrauterine growth restriction and postnatal growth failure—can overlap with other conditions, many individuals remain undiagnosed or are misdiagnosed. Currently, 263 people with Russell Silver Syndrome have joined the DiseaseMaps community, providing valuable real-world insights that complement the limited clinical data available in medical literature.

How does Russell Silver Syndrome affect different populations?

Research indicates that Russell Silver Syndrome affects males and females with equal frequency. There is no currently recognized geographic or ethnic predisposition, suggesting that the condition occurs globally at similar rates. The condition is primarily identified in the pediatric population due to its hallmark growth characteristics, though individuals with Russell Silver Syndrome live into adulthood, where they may face ongoing metabolic and orthopedic challenges.

What challenges exist in tracking the prevalence of Russell Silver Syndrome?

Accurately calculating the number of people living with Russell Silver Syndrome is difficult for several reasons:

• Genetic Heterogeneity: Approximately 50% of cases are linked to hypomethylation of the H19/IGF2 region on chromosome 11p15, while 10% involve maternal uniparental disomy of chromosome 7; the remaining cases have no identified genetic cause.


• Clinical Variability: The spectrum of symptoms is broad, leading to missed diagnoses in milder cases.


• Diagnostic Evolution: Improvements in molecular testing are only recently allowing for more accurate identification of Russell Silver Syndrome cases that were previously categorized as idiopathic short stature.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis through molecular testing.


• Connect with the 263 members of the DiseaseMaps community to share experiences and coping strategies for managing Russell Silver Syndrome.


• Monitor growth and metabolic health through a multidisciplinary team, including endocrinologists and nutritionists.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• Orphanet: Russell-Silver Syndrome (ORPHA:791)


• NIH Genetic and Rare Diseases Information Center (GARD): Silver-Russell Syndrome


• OMIM: Silver-Russell Syndrome (Entry #180860)


• MAGIC Foundation: Silver-Russell Syndrome Patient Education Resources